Since there is no abstract we provide the first sentence
Although laparoscopic gastrectomy is unlikely to improving survival or cure rates for gastric cancer patients, strong evidence indicates its superiority over open gastrectomy in improving quality of life (QOL). Another important field of laparoscopic approach is its clinical use in the risk-reducing prophylactic gastrectomy. But particularly for these healthy individuals, who are carriers of mutations in CDH1, the safety and efficacy is precondition for the clinical application of the laparoscopic approach [1].
